REGENERON PHARMACEUTICALS
| Manager | % of Portfolio | Activity | Shares | Value | Period |
|---|---|---|---|---|---|
| Harry Burn | 3.91% | Reduce 14% | 151.0K | $116.6M | Q1 2026 |
| Mason Hawkins | 4.77% | Add 18% | 138.6K | $107.0M | Q4 2025 |
| Dodge & Cox | 1.92% | Add 1% | 4.60M | $3.55B | Q4 2025 |
| Michael Burry | 0.00% | Sell 100% | 0 | $0 | Q3 2025 |
| Viking Global Investors | 0.00% | Sell 100% | 0 | $0 | Q2 2025 |